Related Experiment Videos
Phosphorylation reactions of recombinant human myotonic dystrophy protein kinase and their inhibition
P W Dunne1, E T Walch, H F Epstein
1Department of Neurology, Baylor College of Medicine, Houston, Texas 77030.
Abstract:
The predicted protein kinase activity of the cloned gene product of the human myotonic dystrophy locus has been experimentally verified. Affinity-purified recombinant DM protein kinase became phosphorylated itself and transphosphorylated histone H1. These activities were not present in the bacterial host cells and were exhibited by DMPK and DMPKH, recombinant proteins which contain the protein kinase domain but exhibit distinct sizes, 43 and 66 kDa, respectively. DMPKH was further purified by velocity sedimentation on sucrose gradients; both activities migrated with the recombinant protein at 41 S, consistent with discrete multimeric particles. Phosphoamino acid analysis showed that threonine (predominantly) and serine were phosphorylated in both DMPKH and histone H1. Although PKA and PKC are the known types of protein kinase with closest sequence homology to the DM protein kinase domain, purified DMPKH was inhibited by 4 mM but not 0.04-0.4 mM H7 and H8, which inhibit PKA and PKC with Ki's of 0.4-15 microM. Specific inhibitors of other classes of multifunctional serine/threonine protein kinases such as casein kinases I (CKI-7) and II (heparin) and calcium/calmodulin-dependent protein kinase II (KN-62) did not inhibit DMPKH. DMPKH did not phosphorylate membrane-associated phosphoproteins such as acetylcholine receptor or spectrin which are known to be substrates for PKA, PKC, and CKI and -II, respectively. These experimental results suggest that the active center of the recombinant human myotonic dystrophy protein kinase may have properties distinct from the well-studied classes of serine/threonine protein kinases, in contrast to predictions based upon primary structure alone.
Insights
The protein kinase activity of the human myotonic dystrophy gene product was confirmed experimentally. This DM protein kinase exhibits unique properties distinct from other known serine/threonine protein kinases.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- The human myotonic dystrophy locus gene product was predicted to have protein kinase activity.
- Experimental verification of this activity was needed to understand its function.
Purpose of the Study:
- To experimentally verify the protein kinase activity of the cloned gene product from the human myotonic dystrophy locus.
- To characterize the enzymatic properties of the DM protein kinase and compare it to known kinases.
Main Methods:
- Recombinant DM protein kinase (DMPK and DMPKH) was expressed and purified.
- Enzymatic assays were performed, including autophosphorylation, histone H1 transphosphorylation, and substrate specificity studies.
- Inhibition assays using specific kinase inhibitors (H7, H8, CKI-7, heparin, KN-62) were conducted.
- Phosphoamino acid analysis was performed.
Main Results:
- Recombinant DM protein kinase (DMPKH) demonstrated autophosphorylation and histone H1 transphosphorylation activity.
- The kinase activity was associated with multimeric particles of DMPKH.
- Phosphorylation occurred predominantly on threonine residues.
- DMPKH was not inhibited by common inhibitors of PKA, PKC, CKI, or CaMKII.
- DMPKH did not phosphorylate known substrates of these kinases, such as acetylcholine receptor or spectrin.
Conclusions:
- The experimental results confirm the protein kinase activity of the human myotonic dystrophy gene product.
- The DM protein kinase exhibits unique enzymatic properties distinct from well-characterized serine/threonine protein kinases.
- These findings suggest that primary sequence homology alone may not fully predict the functional characteristics of this kinase.